News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
43,473 Results
Type
Article (3854)
Company Profile (5)
Press Release (39614)
Section
Business (12169)
Career Advice (73)
Deals (1911)
Drug Delivery (5)
Drug Development (4467)
Employer Resources (2)
FDA (587)
Job Trends (643)
News (19548)
Policy (1608)
Tag
Academia (260)
Adcomms (1)
Allergies (3)
Alliances (4457)
ALS (16)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (2)
Approvals (594)
Artificial intelligence (20)
Automation (2)
Bankruptcy (9)
Best Places to Work (430)
BIOSECURE Act (2)
Biosimilars (2)
Biotechnology (9)
Breast cancer (4)
Cancer (61)
Cardiovascular disease (5)
Career advice (74)
Career pathing (2)
CAR-T (3)
Cell therapy (9)
Clinical research (3449)
Collaboration (50)
Compensation (11)
Complete response letters (1)
COVID-19 (162)
CRISPR (4)
C-suite (15)
Cystic fibrosis (4)
Data (111)
Depression (3)
Diabetes (9)
Diagnostics (287)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (1)
Drug shortages (3)
Duchenne muscular dystrophy (1)
Earnings (2967)
Editorial (1)
Employer resources (2)
Events (4176)
Executive appointments (36)
FDA (643)
Funding (44)
Gene editing (6)
Generative AI (2)
Gene therapy (8)
GLP-1 (46)
Government (219)
Grass and pollen (1)
Healthcare (501)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (3)
Infectious disease (168)
Inflammatory bowel disease (7)
Influenza (5)
Intellectual property (9)
Interviews (4)
IPO (584)
Job creations (220)
Job search strategy (70)
Labor market (1)
Layoffs (13)
Legal (318)
Liver cancer (2)
Lung cancer (9)
Lymphoma (1)
Manufacturing (30)
MASH (3)
Medical device (356)
Medtech (356)
Mergers & acquisitions (1356)
Metabolic disorders (22)
Multiple sclerosis (2)
NASH (2)
Neurodegenerative disease (6)
Neuropsychiatric disorders (1)
Neuroscience (102)
NextGen: Class of 2025 (319)
Non-profit (124)
Now hiring (2)
Obesity (11)
Opinion (15)
Ovarian cancer (4)
Pain (4)
Pancreatic cancer (1)
Parkinson's disease (24)
Partnered (2)
Patents (18)
Patient recruitment (4)
Peanut (1)
People (3879)
Pharmaceutical (1)
Phase I (1123)
Phase II (1507)
Phase III (1043)
Pipeline (52)
Policy (4)
Postmarket research (114)
Preclinical (733)
Press Release (6)
Prostate cancer (7)
Psychedelics (2)
Radiopharmaceuticals (5)
Rare diseases (14)
Real estate (488)
Recruiting (1)
Regulatory (1167)
Reports (5)
Research institute (198)
Resumes & cover letters (1)
RSV (2)
Schizophrenia (7)
Series A (7)
Series B (4)
Sickle cell disease (1)
Spinal muscular atrophy (8)
Sponsored (3)
Startups (297)
Supply chain (3)
Tariffs (1)
Vaccines (21)
Venture capitalists (3)
Weight loss (7)
Date
Today (7)
Last 7 days (34)
Last 30 days (106)
Last 365 days (1524)
2025 (436)
2024 (1749)
2023 (2244)
2022 (4889)
2021 (4052)
2020 (2844)
2019 (2496)
2018 (1923)
2017 (2199)
2016 (2248)
2015 (2663)
2014 (2084)
2013 (1650)
2012 (1796)
2011 (2012)
2010 (1555)
Location
Africa (54)
Alabama (1)
Arizona (8)
Arkansas (1)
Asia (2785)
Australia (425)
California (336)
Canada (95)
China (25)
Colorado (19)
Connecticut (12)
Delaware (1)
Europe (6874)
Florida (59)
Georgia (1)
Idaho (4)
Illinois (15)
Indiana (7)
Japan (12)
Kansas (6)
Louisiana (1)
Maine (2)
Maryland (43)
Massachusetts (184)
Michigan (5)
Minnesota (17)
Missouri (2)
Nebraska (1)
New Jersey (83)
New Mexico (1)
New York (45)
North Carolina (43)
Northern California (156)
Ohio (7)
Oklahoma (2)
Oregon (1)
Pennsylvania (39)
Puerto Rico (2)
Rhode Island (1)
South America (85)
South Carolina (1)
Southern California (133)
Tennessee (1)
Texas (22)
United States (984)
Utah (16)
Virginia (6)
Washington State (12)
Wisconsin (1)
43,473 Results for "mitsubishi chemical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America Announces Publication of Preclinical Research on the Role of Edaravone in Mitigating TDP-43 Mislocalization in ALS
March 26, 2025
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America to Share Latest Data on Investigational ND0612 at the 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)
April 1, 2025
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America to Highlight Latest Advances in Neurodegenerative Research at the American Academy of Neurology 2025 Annual Meeting
April 3, 2025
·
10 min read
Press Releases
Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
March 12, 2025
·
9 min read
Press Releases
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (edaravone) in ALS
January 30, 2025
·
8 min read
Pharm Country
Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community
Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.
May 23, 2024
·
6 min read
Pharm Country
Mitsubishi Tanabe Pharma America Celebrates Second Anniversary of RADICAVA ORS® (edaravone) Launch in the U.S.
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the two-year launch anniversary of RADICAVA ORS ® (edaravone) in the U.S.
June 17, 2024
·
10 min read
Pharm Country
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S.
Mitsubishi Tanabe Pharma America, Inc. is celebrating its eight-year anniversary of being established in the United States.
April 29, 2024
·
10 min read
1 of 4,348
Next
